A canine sepsis model that simulates the human cardiovascular response to septic shock was produced in 10 conscious unsedated dogs by implanting an Eschichia coli-infected clot into the peritoneum, resulting in bacteremia. By employing serial, simultaneous measurements of radionuclide scan-determined left ventricular (LV) ejection fraction (EF) and thermodilution cardiac index (CI), the end-diastolic volume index (EDVI) was calculated (EDVI = stroke volume index + EF). By using three different methods of quantifying serial ventricular performance (EF, shifts in the Starling ventricular function curve using EDVI vs. stroke work index, and the ventricular function curve response to volume infusion), this study provides evidence (P < 0.01) that septic shock produces a profound, but reversible, decrease in systolic ventricular performance. This decreased performance was not seen in controls and was associated with ventricular dilatation (P < 0.01); the latter response was dependent on an adequate volume infusion. Further studies of EDVI and pulmonary capillary wedge pressure during diastole revealed a significant, though reversible, shift (P < 0.001) in the diastolic volume/ pressure (or compliance) relationship during septic shock.
Introduction
Shock secondary to sepsis has become one of the most frequent causes of morbidity and mortality in clinical medicine, despite the availability ofhighly potent antibiotic regimens (1, 2) . Septic shock has become the most common cause ofdeath in intensive care units in the United States (3) (4) (5) . A better understanding of the pathogenesis of the septic shock syndrome can lead to more effective treatment regimens (6) ; however, septic shock in humans is difficult to study because the disease is very serious with a high mortality (1, 2) . Thus, septic shock must be treated with state-of-the-art fluid and pharmacologic therapy as soon as possible. These limitations on human investigation make it imperative to develop an animal model of septic shock to investigate more fully the treatment and pathogenesis of this highly lethal syndrome.
Most animal models of septic shock do not produce a cardiovascular profile similar to that seen in humans (3, 7) . Recent studies of human septic shock have shown clearly that the most common initial cardiovascular pattern consists of a high cardiac index (CI),' a decreased systemic vascular resistance index (SVRI), and a normal or low measure of preload, most commonly expressed clinically as a decreased pulmonary capillary wedge pressure (PCWP) (7) (8) (9) (10) (11) (12) (13) (14) (15) . In a recent evaluation of septic shock patients (16) , these hemodynamic parameters were further defined by performing simultaneous measurements of radionuclide-gated blood pool scans along with the intravascular catheter-derived hemodynamic parameters. These latter studies provide strong evidence that most septic shock patients develop a decreased left ventricular (LV) ejection fraction (EF) and dilatation of the left ventricle, along with the increased CI and decreased SVRI and PCWP described above. Furthermore, it is important to realize that these cardiovascular evaluations were performed on humans who were receiving a large amount of fluid replacement in order to increase the mean arterial pressure (MAP) to the normal range.
Animal models of sepsis have frequently employed a large lethal dose of intravenous endotoxin or live bacteria which resulted in an animal's death in 3-6 h. This model produced a low CI and high SVRI, a hemodynamic pattern not typical of that seen in humans. In these studies, the animal would usually receive no (or only maintenance) fluid therapy and would die within a few hours with a very low CI. This is a temporal pattern that was rarely seen with humans (3, 7, (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) .
In the present study, a canine model of septic shock was modified with the purpose of simulating, as closely as possible, the cardiovascular dysfunction seen with human sepsis. A recently developed animal model was utilized where live Gramnegative bacteria were introduced into the peritoneal cavity in a fibrin clot as a nidus of infection resulting in sustained bacteremia (28) . Serial determinations ofboth intravascular catheterdetermined hemodynamics and simultaneous radionuclide cineangiograms were performed in conscious unsedated animals to evaluate fully the systolic and diastolic ventricular function in the absence of the effects of anesthesia. The animals were evaluated before and after volume challenge to simulate fully the human clinical course. This study demonstrates that this model simulates both the "hyperdynamic" state and the severe reversible myocardial decrease in EF, a profile that had been previously described in humans (16) . This study also demonstrates the role of fluid therapy in producing this abnormal cardiovascular pattern, and provides further insight regarding the systolic and diastolic ventricular dysfunction evidenced during bacteremia.
Methods
Experimental design. The protocol followed in these experiments is shown in Fig. 1 . Employing only local anesthesia with 1% lidocaine, femoral and pulmonary artery catheters were placed in awake animals at I wk prior to surgery to obtain hemodynamic and laboratory data at the baseline time point. Blood was cultured and routine laboratory tests performed (please see subsection "Laboratory data"). In conscious animals, simultaneous hemodynamic data was obtained from both intravascular catheters and the gated-radionuclide cineangiogram of the LV. The animals then received a volume infusion (VI) (see below), and complete hemodynamic and radionuclide studies were repeated. This comprehensive evaluation was performed in 60-120 min and all catheters were then removed. Surgery was performed at day 0 with placement of a clot, either sterile (control) or infected. The comprehensive evaluation initially performed at baseline was repeated at days 1, 2, and 10.
Surgical procedure. Sixteen 2-yr-old male beagles weighing a mean±SEM of 12.5±0.4 kg were used in these experiments. Animals had free access to water and food throughout the study, except for the 12 hours preoperatively, i.e., prior to surgical implantation of a sterile or infected clot into the peritoneum (see below). Anesthesia was induced with sodium pentobarbitol (20 mg/kg) and maintained with spontaneous ventilation via an endotracheal tube with 1% halothane and 00%o oxygen.
An upper abdominal midline laparotomy was performed, using aseptic technique. Bacterial peritonitis was induced in 10 dogs by implanting into the abdominal cavity a fibrin-thrombin clot containing viable Escherichia coli. A sterile fibrin-thrombin clot was implanted into the abdomen of six control dogs. After implantation of the infected or sterile clot, the incision was sutured closed and dressed. Please note that no cardiovascular evaluation was performed in close proximity to this general anesthesia and surgery (see Fig. 1 ) because anesthesia and surgery may alter cardiovascular function.
Preparation offibrin clot. The clots were prepared as previously described (28 of the dog (10 ml/kg). The fibrinogen was sterilized by passage through 0.02-pum Nalgene filters. The calculated dose of bacteria (see below), suspended in 10 ml of saline, was added to the fibrinogen solution and mixed with a magnetic stirrer. The clot was formed by adding human thrombin (5 U/ml fibrinogen solution) to the above solution and the resulting mixture was incubated at room temperature for 30 min. The strain ofE. coli used in these studies was provided by Dr. Lerner B. Hinshaw and was originally isolated from a patient with urinary tract sepsis. The bacteria were stored at -70°C in 1-ml aliquots in brain-heart infusion broth and glycerol. For preparation of an infected fibrin clot, 500 ml of brain-heart infusion was inoculated with a l-ml aliquot of thawed bacteria. The bacteria were incubated for 18 h, centrifuged, and were then washed twice in sterile saline. The concentration of bacteria in the final suspension was estimated turbidimetrically by comparing the newly grown bacterial suspension to known standards and subsequently bacteria were quantified by plating successive 10-fold dilutions of the bacterial suspension onto MacConkey's agar and scoring visible colonies after 24 h ofincubation at 37°C. Based on results in preliminary studies, the target dose was 14 X 109 viable organisms per kilogram of body weight. The actual dose, as calculated by the dilution method outlined above, was a mean±standard error of the mean of 15.5±0.3 X 109 organisms per kilogram of body weight.
Placement ofcatheters. Femoral and pulmonary artery catheters were placed in awake animals using aseptic technique and only local anesthesia (1% lidocaine). A 7.5 French Swan-Ganz thermodilution catheter with a 15-m proximal injection port (Edwards Laboratories, Santa Ana, CA) was introduced through an 8.0 French introducer (Cordis Corporation, Miami, FL) placed percutaneously via the external jugular vein into the pulmonary artery and positioned so that the PCWP could be measured repeatedly with balloon inflation. A 20-gauge X 12.7-cm Teflon catheter (Arrow International, Reading, PA) was introduced percutaneously into the femoral artery. These catheters were placed at four time points: 1 wk prior to surgery (baseline), days 1 and 2 postsurgery when the animals had bacteremia, and 10 days postsurgery when they were recovering (recovery). After performing the hemodynamic profiles, all catheters in each dog were completely removed each day.
Physiologic measurements. All measurements made from indwelling catheters were performed in unanesthetized animals that were resting quietly in slings. Cardiac output (CO) was determined by the thermodilution method, using a Waters TC-2 computer (Waters Instruments, Inc., Rochester, MN). MAP, pulmonary arterial pressure (PAP), central venous pressure (CVP), and PCWP, were measured with transducers (MK-404 DT, Sorenson, Salt Lake City, UT) and recorded on a fourchannel recorder (Hewlett-Packard Co., Palo Alto, CA). Heart rate (HR) was determined from the arterial pressure tracings. Serial hemodynamic measurements were made prior to and after infusion oflactated Ringer's solution at a dose of 80 ml/kg body weight given over 1 h at the four following time points: baseline, day 1, day 2, and recovery. (29) . The hatched rectangles shown in Fig. 2 A and B represent the mean values for 51 normal dogs and the respective standard error (Table I) adjusted to the number of septic dogs (10) and control dogs (6) for purposes of comparison. Two-sample t tests were used to compare means of sterile and infected clot dogs and for laboratory data.
In Fig. 7 A and B, in order to perform appropriate statistical comparisons of the serial time points in sterile and septic clot groups, the average or midpoint of each pre-and post-VI line was calculated by subtracting the pre from the postvalue for EDVI and PCWP for each dog, and dividing in half. Each of these determinations is then added to the respective pre-VI value to obtain the midpoint ofeach pre-and post-VI line. These EDVI and PCWP values were averaged and are represented by black dots as the midpoints of the gray lines plotted in Fig. 7 A and B.
Because a major question in these experiments was whether the ventricular volume/pressure relationship was normal at different serial time points in the sterile or septic clot dogs, all serial time points were compared to normal. The normals were represented by both the 10 septic and 6 sterile clot dogs at baseline, i.e., values derived before any surgery or intervention had been performed. Please note that the pressure employed in Fig. 7 was the PCWP during diastole (from the arterial and ECG 
Results

Blood cultures and clinical manifestations. For the first 2 d after
surgery, all the dogs implanted with a septic clot had uniformly positive blood cultures. In all dogs, the organism grown from the blood was an E. coli, the same genus and species as the microorganism that was implanted into the abdomen. The blood cultures were sterile at baseline and recovery. During the first 3 d after surgery, the bacteremic dogs were febrile (Table II) Fig. 2 A shows that at baseline, in the infected dogs, the means of each of the four hemodynamic parameters were close to or within the normal range for dogs, whereas after VI there was a statistically significant (P < 0.01) elevation of mean MAP, CI, PCWP, and a significant (P < 0.01) decrease in mean SVRI.
In infected dogs on day 1 of bacteremia, prior to VI, the mean MAP and CI decreased significantly compared to baseline from 124±3 to 95±3.5 mmHg (P < 0.001) and 275±22 to 209±24 ml/kg/min (P < 0.05), respectively. Mean PCWP and SVRI showed no significant change from baseline. On day 1, VI restored the mean (±SEM) MAP from 95±3.5 to 132±3 mmHg (i.e., no significant change from baseline pre-VI value of 124±3 mmHg). The VI has increased the bacteremia-induced depressed mean MAP back up to the "normal" range, but mean CI was significantly (P < 0.01) elevated to 366±27 ml/kg/min compared to the baseline pre-VI value of 275±22 ml/kg/min. In addition, on day 1, post-VI the mean SVRI had decreased significantly (P < 0.01) from pre-VI baseline value of 39.2±3.5 to 28.3±2.3 dynes * s * cm-5/kg, respectively. Thus, on day 1, the post-VI hemodynamic profile was a hyperdynamic cardiovascular profile, i.e., a high CO and low SVRI.
To summarize, in bacteremic dogs, when preload is low, as evidenced by a low or normal mean PCWP prior to VI on day 1, the mean MAP and mean CI were decreased with a normal SVRI. Increasing preload restored the mean MAP to near normal, elevated mean CI, and a decreased mean SVRI. Thus, in this canine model the hyperdynamic profile ofsepsis was preloaddependent.
In infected dogs on day 1 and 2 pre-VI, the systemic hemodynamics were not statistically different. On day 2, compared with day 1, VI increased CI to the normal range, but not supranormal levels. On day 2, compared with day 1, VI decreased SVRI to just below the normal range not statistically significantly decreased compared to the baseline pre-VI values. By day 10 (recovery), all four parameters had returned toward normal.
An overview of Fig. 2 A shows significant trends in hemodynamic values over time, both in terms of pre-and post-VI values. On days 1 and 2 both the MAP and the CI shifted down from the preoperative baseline values, and by day 10 these values returned toward baseline. In contrast, the SVRI (a ratio of the MAP and CI) showed very little serial change pre-and post-VI throughout. The PCWP showed no significant change pre-VI over serial time points, but at baseline post-VI the PCWP decreased compared to day 1, day 2, and recovery values.
In the control (nonseptic) dogs (Fig. 2 B) , there was no significant mean change from baseline in any hemodynamic parameter at days 1 and 2, and recovery, other than a decreased PCWP (P < 0.05) on day 1 pre-VI. The responses to VI at all time points in the control group were similar to that at baseline.
Serial EFs. Serial EFs as determined by radionuclide scan (prior to VI) are shown in Fig. 3 . The data for septic dogs are in Fig. 3 A and sterile clot dogs in Fig. 3 B. On the day of maximal change in EF, there was a highly significant (P < 0.001) decrease in mean EF compared with baseline in septic animals. There was no significant change in the EF in control dogs. EF decreased significantly (P < 0.001) in septic animals as compared with control animals. There was no difference between the recovery EF and initial EF in the septic or control group. In 9 of 10 septic dogs the maximal decrease in EF occurred on day 2 and in one dog it occurred on day 3. Thus, septic animals developed profound decreases in EF during the 2-3 d after the onset of sepsis and recovered by 7-10 d. VI induced no significant changes (P = NS) in mean EF in each day in all canines (sterile and infected) animals.
Shifts in ventricularfunction. Employing a plot of EDVI vs. LVSWI, Fig. 4 depicts each individual dog's (thin black arrows) and the mean (thick gray arrows) shift in cardiovascular function after the peritonitis-induced bacteremia. From baseline to day 1 (top panel), all 10 bacteremic dogs showed a decrease in LVSWI and 8 of 10 dogs had a decrease in EDVI (Fig. 4) . From Comparing baseline to day 1, the bacteremic dogs had both a 0.85±0.22 ml/kg mean decrease (P < 0.01) in EDVI and a 1.64±0.21 g-m/kg mean decrease (P < 0.001) in LVSWI. Then, from day 1 to day 2 the bacteremic dogs had a 1.48±0.3 ml/kg mean increase (P < 0.001) in EDVI, and an insignificant 0.16±0.13 g-m/kg mean increase in LVSWI. From day 2 to recovery, the bacteremic dogs had an insignificant 0.30±0.33 ml/kg mean decrease in EDVI and a 1.96±0.15 g-m/kg mean increase (P < 0.001) in LVSWI. In control dogs, no significant mean changes occurred from baseline to day 1, day 1 to day 2, or from day 2 to recovery (see Fig. 5 B) .
Comparing the bacteremic and noninfected dogs from baseline to day 1, there was no significant difference in the change in EDVI but there was a more profound decrease (P < 0.05) in LVSWI in bacteremic dogs. From day 1 to day 2, there was a profound increase (P < 0.01) in EDVI in bacteremic dogs with no significant difference in the small day 1 LVSWI change, i.e., in only bacteremic dogs the ventricle dilated between days 1 and 2 with no significant change in the already depressed LVSWI.
From day 2 to recovery, there was no significant difference in the mean change in EDVI, but the bacteremic dogs had a large increase (P < 0.01) in mean LVSWI, showing a return of ventricular performance towards baseline.
In summary, bacteremic dogs had a significant mean decrease in EDVI and LVSWI on day 1. From day 1 to day 2 in the bacteremic dogs the ventricle dilated (increased EDVI) and maintained the same poor ventricular performance (decreased LVSWI). From day 2 to recovery, the mean ventricular performance improved in infected dogs and returned toward baseline. The sterile clot dogs had no significant shift in mean ventricular function throughout.
Ventricularfunction after VI. Fig. 6 displays the mean ventricular response to VI at baseline, day 1, day 2, and recovery. At baseline, VI greatly increased (P < 0.01) mean LVSWI and minimally increased (P = NS) mean EDVI. On day 1, day 2, and recovery time points, the response to VI showed statistically significant increases (P < 0.05) in both mean EDVI and mean LVSWI. Fig. 6 shows that on day 1 VI reversed the bacteremia-induced depression of mean LVSWI to near baseline pre-VI (note the position of the arrow tip for day 1 value). The ability of volume to restore ventricular function to prebacteremia performance indicates that the defect on day 1 can be restored at least partially toward normal by increasing preload. On day 2 VI induced statistically significant (P < 0.01) ventricular dilatation, but the ventricular performance did not return to near baseline post-VI value (note position ofarrow tip for day 2 value in Fig. 6 ). On day 2, ventricular performance was decreased, although mean ventricular volume 4.79 ml/kg was greater (P < 0.01) when compared to the pre-or post-VI values seen at baseline (see Fig. 6 ). This decrease in performance could result from decreased HR, increased afterload, or decreased intrinsic contractility. However, on day 2 post-VI, HR was greater than baseline (P < 0.02) and afterload, i.e., the MAP and SVRI, were not statistically elevated. Thus, the downward shift in the ventricular function curve appears to result from a decrease in the intrinsic contractility of the left ventricle.
By recovery, VI produces changes in ventricular function and ventricular size that were very similar to baseline values. The control dogs showed no significant shifts in ventricular performance or size pre-or post-VI throughout the study.
Analysis ofthe shifts in the relationship ofED VI and PCWP. Fig. 7 shows the relationship between the mean EDVI and the mean PCWP pre-and post-VI on serial days in infected dogs ( Fig. 7 A) and sterile clot dogs (Fig. 7 B) . The mean shift in the relationship between serial time points (baseline, day 1, day 2, and recovery) is derived from the midpoint values (see statistical methods) for EDVI and PCWP from the pre-to post-VI points for each dog on each day. The midpoint differences for each dog between days were determined and averaged, and these changes are compared to evaluate whether the changes occurred in the EDVI or PCWP or both.
In comparing the pre-and post-VI midpoint shift in EDVI and PCWP from baseline to day 1, the bacteremic dogs had a mean 0. 14±0.11 ml/kg decrease (P = NS) in EDVI and a mean 0.6±1.26 mmHg increase (P = NS) in PCWP.
Between days 1 and 2, there was a substantial change in the volume/pressure relationship in diastole for the bacteremic dogs (note the midpoint shift Fig. 7 A) . A profound 1.17±0.19 ml/ kg increase (P < 0.001) occurred in EDVI, and there was a small 0.9±1.35 mmHg increase (P = NS) in PCWP. In the sterile clot (control) dogs (Fig. 7 B) , no significant changes occurred in EDVI or PCWP at any time points comparing day 1, day 2, and recovery with baseline values.
In summary, a comparison ofbaseline and serial time points in bacteremic dogs, demonstrated that the EDVI and PCWP were not significantly changed at day 1. At day 2 in bacteremic dogs, the EDVI was substantially increased without a change in pressure. This day 2 change suggests an increase in compliance, allowing an increase in ventricular volume without an increase in pressure.
Laboratory data. Tables III and IV show serial mean values for common clinical laboratory parameters obtained in bacter- emic and control dogs, respectively. Table V shows the serial mean weights for the infected and control dogs. The weights provide further serial data that can be used to more fully evaluate serial volume status. The bacteremic dogs at day 1 had a metabolic acidosis (with full respiratory compensation) with a decrease in calculated bicarbonate to 19±1 meq/liter (P < 0.001) from a bwseline of 21±0.3 meq/liter. However, arterial blood pH remained normal. On day 1, there was also a decrease in platelet counts from baseline value of 374±45 X 1,000/mm3 to 189±21 X 1,000/mm3 (P < 0.01). On day 2 the bacteremic dogs had the following abnormalities: metabolic acidosis compared to baseline value (P < 0.01) with the persistence of respiratory compensation noted on day 1; an elevated white blood count (21±2 X 1,000/mm3 from a baseline of 11.8±1 X 1,000/mm3 [P < 0.02]); decreased hematocrit (0.37±0.02 from a baseline of 0.46±0.03 [P < 0.05]); and a more pronounced thrombocytopenia (96±12 X 1,000/mm3 from a baseline of 374±45 X 1,000/mm3 [P < 0.001]). By day 10 the metabolic acidosis and the thrombocytopenia have resolved, but the anemia (P < 0.01), and the elevated white blood count (P < 0.01) have persisted.
On day 1 after surgery the sterile clot dogs also have a decreased bicarbonate of 17±1 meq/liter from a baseline 22±.5 meq/liter (P < 0.05) with respiratory compensation. At day 2 the sterile clot dogs' metabolic parameters are all within normal ranges. By day 10 the sterile clot dogs have a mild anemia and an elevated white blood count.
All hemodynamic studies were performed on dogs with normal serum pH and P02. No dog had a severe abnormality of blood chemistries (Na, K, CO2, Cl, Glu, or Ca) that could have accounted for the decrease in cardiovascular function.
Discussion
This study demonstrates that significant reversible systolic myocardial depression and ventricular dilatation, as well as diastolic PV forkontS*---.. are evaluated without anesthesia or sedation, because these latter Figs. 4 and 5) .
Another method ofevaluating ventricular performance employed in this study was to evaluate the response to VI. A twopoint ventricular function curve was constructed on each dog at every time point by plotting the pre-and post-VI response in ventricular volume and performance. The day 1 decrease in ventricular performance could be brought back to near baseline with VI, i.e., the decrease was preload-dependent (see Fig. 6 ). However, VI at day 2 after bacteremia failed to increase ventricular performance back to baseline levels despite increasing preload (as measured by pressure [PCWP] or volume, [EDVI] parameters) to supranormal levels. The ventricular dysfunction on day 2 after bacteremia probably results from a decrease in the intrinsic contractility of the left ventricle.
Thus, in this canine model, bacteremia induces both a preload-dependent (day 1) and a preload-independent (day 2) decrease in ventricular performance. The pathogenesis of this systolic ventricular dysfunction is not known. Recent studies in human septic shock have demonstrated that coronary blood flow is not a likely etiology (38) . However, other recently completed investigations present strong evidence that a circulating myocardial depressant substance is probably the cause of the decreased EF in human septic shock (39) . The role ofother recently described circulating substances in the pathogenesis of septic shock will require further investigations.
Previous studies of animals or humans did not describe the myocardial depression so clearly evidenced in the present study because many prior investigations only evaluated myocardial function for several hours after the onset ofsepsis (40, 41) (43, 44) . Although this property has been defined in slightly different ways by different authors, all agree that it represents the relationship between ventricular volume and ventricular pressure. Since this relationship is neither linear nor clearly exponential, most authors have not employed a purely mathematical model ofthe volume/pressure relationship, but rather have demonstrated shifts in the volume/pressure curve with physiologic interventions (45) (46) (47) (48) (49) .
In the present study, thermodilution cardiac outputs and radionuclide-gated blood pool scans were performed simultaneously (both within 2-3 min) allowing calculation ofventricular volumes (see above in Methods) at the same time that ventricular pressures and cardiac outputs (flows) were being measured. Then, each dog at each time point received an identical rapid fluid infusion and the studies were repeated. This allowed determination ofthe volume/pressure relationship, both before and after the ventricle was distended by the administration of fluid (Fig.  7) . Bacteremia produced significant changes in diastolic ventricular function. This diastolic abnormality was characterized by a significant increase in volume in relationship to pressure when compared to normal ventricles at baseline. The maximal diastolic abnormality was seen on day 2 when there was massive LV dilatation without a significant change in pressure. Whether this diastolic abnormality is a direct consequence ofbacteremia, or represents a compensatory mechanism of the ventricle to allow a larger diastolic volume without a pressure increase that would produce pulmonary edema, is not known. No previous study has demonstrated a change in the diastolic ventricular volume/pressure relationship due to sepsis, although increases and decreases in ventricular compliance have been described at different times after acute myocardial ischemia (43) . Elucidation ofthe cause ofthis ventricular diastolic abnormality will require further investigation.
Recently, Ziegler et al. (6) employed insights regarding the pathogenesis of sepsis to devise improved therapy. This study describes profound systolic and diastolic abnormalities that are potential sites for an improved therapeutic regimen in this highly lethal disease.
